HLA-A11-associated resistance to skin cancer in renal-transplant recipients.

Retinoids to prevent skin cancer in organ transplant recipients.

Skin cancer in kidney transplant recipients.

Genetics and nonmelanoma skin cancer in kidney transplant recipients.

Chemotherapy resistance mechanisms in advanced skin cancer

Chemotherapy Resistance Mechanisms in Advanced Skin Cancer.

The cutting edge of skin cancer in transplant recipients: scientific retreat of international transplant Skin Cancer Collaborative and Skin Cancer in Organ Transplant Patients Europe.

Skin lesions in kidney transplant recipients.

Non-melanoma skin cancer in renal transplant recipients: a study in a Brazilian reference center.

Relation between skin cancer and HLA antigens in renal-transplant recipients.

Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?

Yearly Burden of Skin Cancer in Non-Caucasian and Caucasian Solid-organ Transplant Recipients.

The incidence and risk factors of de novo skin cancer in the liver transplant recipients.

Skin cancer in organ transplant recipients: more than the immune system.

Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.

Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center.

Management of non-melanoma skin cancer in solid organ transplant recipients.

Malignant and noninvasive skin tumours in renal transplant recipients.

Cyclosporin A reduces skin collagen content in renal graft recipients.

Infection: Resistance to infection--skin adipocytes in the spotlight.

The incidence of aspirin resistance in heart transplantation recipients.

Reply to 'skin cancer, photoprotection, and skin of color'.

Insulin resistance and skin diseases.

Primary lung cancer in lung transplant recipients.

Resistance to Raf inhibition in cancer.

Suggest Documents

Retinoids to prevent skin cancer in organ transplant recipients.

Skin cancer in kidney transplant recipients.

Genetics and nonmelanoma skin cancer in kidney transplant recipients.

Chemotherapy resistance mechanisms in advanced skin cancer

Chemotherapy Resistance Mechanisms in Advanced Skin Cancer.

The cutting edge of skin cancer in transplant recipients: scientific retreat of international transplant Skin Cancer Collaborative and Skin Cancer in Organ Transplant Patients Europe.

Skin lesions in kidney transplant recipients.

Non-melanoma skin cancer in renal transplant recipients: a study in a Brazilian reference center.

Relation between skin cancer and HLA antigens in renal-transplant recipients.

Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?

Yearly Burden of Skin Cancer in Non-Caucasian and Caucasian Solid-organ Transplant Recipients.

The incidence and risk factors of de novo skin cancer in the liver transplant recipients.

Skin cancer in organ transplant recipients: more than the immune system.

Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.

Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center.

Management of non-melanoma skin cancer in solid organ transplant recipients.

Malignant and noninvasive skin tumours in renal transplant recipients.

Cyclosporin A reduces skin collagen content in renal graft recipients.

Infection: Resistance to infection--skin adipocytes in the spotlight.

The incidence of aspirin resistance in heart transplantation recipients.

Reply to 'skin cancer, photoprotection, and skin of color'.

Insulin resistance and skin diseases.

Primary lung cancer in lung transplant recipients.

Resistance to Raf inhibition in cancer.

HLA-A11-associated resistance to skin cancer in renal-transplant recipients.

Recommend Documents

Follow Us